Imran Talat reported RANI

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001869579-26-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 3, 2026

Published

Jun 5, 2026

Ingested by INSIDER

Nov 5, 03:54 UTC

Last re-read

Nov 5, 03:54 UTC

Extracted facts

Filer

Imran Talat

Role

Director, Chief Executive Officer

Transaction

Grant or awardAs filed: “A”

Asset

Rani Therapeutics Holdings, Inc. — Stock Option (Right to Buy)

Ticker

RANI

Shares

3.80M

Price per share

$0

Execution date (reported)

Jun 3, 2026

Owned after transaction

3.80M shares

Days from execution to publication

2

What this establishes

Imran Talat filed this Form 4 reporting a grant or award of RANI on Jun 3, 2026. It became public on Jun 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Chief Executive Officer

Imran Talatcik:0001869579

Issuer

Rani Therapeutics Holdings, Inc.cik:0001856725

Revision history · 0

No field has changed since this record was first ingested.